Investigation of the diagnosis and treatment of insomnia and the use of related drugs in primary medical institutions in Beijing
10.19845/j.cnki.zfysjjbzz.2026.0050
- VernacularTitle:北京市基层医疗机构失眠诊治及相关药物使用现状调查
- Author:
Fengchun YU
1
Author Information
1. Beijing Neurology Association， Beijing 102218， China
- Publication Type:Journal Article
- Keywords:
Insomnia;
Primary medical institutions;
Sedative-hypnotic drugs;
Research and investigation
- MeSH:
Insomnia, Fatal Familial
- From:
Journal of Apoplexy and Nervous Diseases
2026;43(4):291-294
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the current status of the diagnosis and treatment of insomnia and the clinical use of related drugs in primary medical institutions in Beijing， China through a survey. Methods A questionnaire survey and face-to-face interviews were used to conduct a stratified random sampling survey in primary medical institutions in 16 districts of Beijing. Results The primary medical institutions in Beijing played an important role in the long-term management of insomnia patients， and integrated traditional Chinese and Western medicine therapy is the main treatment paradigm for insomnia. The three most frequently used sedative-hypnotic drugs are estazolam， zolpidem tartrate. At present， there are still several issues in primary medical institutions， including a lack of training on sleep medicine and strict restrictions on the types of sedative-hypnotic drugs. Conclusion Primary medical institutions in Beijing play a significant role in the long-term management of insomnia patients. However， due to a lack of standardized and systematic training on sleep medicine and the limited types and quantities of sedative-hypnotic drugs， there are still difficulties in the standardized diagnosis and treatment of insomnia， as well as the presence of non-standardized use of sedative-hypnotic drugs.
- Full text:2026061213322431345北京市基层医疗机构失眠诊治及相关药物使用现状调查.pdf
